Absci Corporation (ABSI)
8.21
0.00 (0.00%)
Upcoming Events
Latest Headlines
Absci to Participate in Upcoming Investor Conferences
September 1, 2026 8:00 AM - StreetInsider
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
August 19, 2026 8:56 AM - StreetInsider
Absci Corporation (ABSI) Misses Q2 EPS by 2c
August 11, 2026 4:24 PM - StreetInsider
Form 10-Q Absci Corp For: Jun 30
August 11, 2026 4:09 PM - SEC Filing
Form 8-K Absci Corp For: Aug 11
August 11, 2026 4:07 PM - SEC Filing
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
August 11, 2026 4:05 PM - StreetInsider
Form 4 Absci Corp For: Mar 03 Filed by: Somaratne Ransi Mudalinayake
August 7, 2026 4:54 PM - SEC Filing
Form 3 Absci Corp For: Mar 03 Filed by: Somaratne Ransi Mudalinayake
August 7, 2026 4:54 PM - SEC Filing
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
July 14, 2026 4:05 PM - StreetInsider
Form 4 Absci Corp For: Jun 30 Filed by: Szela Mary T
July 6, 2026 4:06 PM - SEC Filing
Absci Corp. (ABSI) PT Raised to $17 at Truist Securities
July 2, 2026 7:07 AM - StreetInsider
Form 4 Absci Corp For: Jun 24 Filed by: McClain Sean
June 26, 2026 4:22 PM - SEC Filing
Absci Corp. (ABSI) PT Raised to $10 at Morgan Stanley
June 25, 2026 8:53 AM - StreetInsider
Absci Corp. (ABSI) PT Raised to $16 at H.C. Wainwright
June 25, 2026 6:46 AM - StreetInsider
Form 8-K Absci Corp For: Jun 24
June 24, 2026 4:32 PM - SEC Filing
Form 424B5 Absci Corp
June 24, 2026 4:31 PM - SEC Filing
Absci Corp. (ABSI) PT Raised to $13 at Jones Trading
June 24, 2026 2:18 PM - StreetInsider
Absci prices $100M stock offering with Eli Lilly among investors
June 24, 2026 6:35 AM - StreetInsider
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
June 24, 2026 6:35 AM - StreetInsider
Form 8-K Absci Corp For: Jun 24
June 24, 2026 6:32 AM - SEC Filing
Absci reports Phase 1 safety data for hair loss antibody ABS-201
June 24, 2026 6:30 AM - StreetInsider
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
June 24, 2026 6:30 AM - StreetInsider
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
June 16, 2026 8:45 AM - PR NewsWire
Full Article List
